Loading...
Loading...
Synergy announces that, earlier today, the Scheme was sanctioned by the High
Court of Justice in England and Wales. In order for the Scheme to become
effective in accordance with its terms, the Court will now need to confirm
the Capital Reduction at the Second Court Hearing, which is scheduled to
take place on 28 October 2015. The scheme becoming effective also remains
conditional upon delivery of a copy of each of the Court Orders and of the
requisite statement of capital to the Registrar of Companies and, if the
Court so orders in order for it to become effective, the registration of the
Reduction Court Order and the statement of capital by the Registrar of
Companies.
Subject to Court confirmation of the associated Capital Reduction and the
timing of the delivery of the Court Orders to Companies House, the Effective
Date of the Scheme is expected to be 2 November 2015.
Synergy Shareholders should note that it is now anticipated that the
listing of, and commencement of dealings in, New STERIS Shares on the New
York Stock Exchange will take place by 9.30 a.m. (EST) on 3 November 2015
(rather than 2 November as stated in the Supplementary Circular dated 21
September 2015 ("Supplementary Circular")).
Today is the last day for dealings in, and for registration of transfers of,
Synergy Shares and it is anticipated that the listing of Synergy Shares on
the premium listing segment of the Official List of the UK Listing Authority
("UKLA") and trading in Synergy Shares on the London Stock Exchange's main
market for listed securities will be suspended by 8.00 a.m. on 28 October
2015. Synergy Shares are also expected to be delisted from the premium
listing segment of the Official List of the UKLA and cancelled from the main
market of the London Stock Exchange by 8.00 a.m. on 3 November 2015.
Upon the Scheme becoming effective, the latest date for despatch of cheques
and settlement through CREST for Cash Consideration and despatch of share
certificates or statements of ownership in respect of New STERIS Shares or
crediting of CREST accounts in respect of the New STERIS Shares or crediting
of CREST accounts in respect of the New STERIS Depositary Interests or
crediting of DTC accounts in respect of New STERIS Shares (as applicable),
in each case due under the Scheme is 16 November 2015.
Other
Unless otherwise stated, all references to time in this announcement are to
London, UK time.
Unless otherwise defined therein, capitalised terms and expressions used in
this announcement shall have the meanings given to them in the Scheme
Document dated 17 February 2015 or the Supplementary Circular.
For Further Information:
Synergy Health plc Tel: +44 (0) 1793 891 851
------------------------------------ -------------------------
Dr Richard Steeves, Chief Executive
------------------------------------ -------------------------
Gavin Hill, Finance Director
------------------------------------ -------------------------
Investec
--------------------------------------------------------
Patrick Robb, Gary Clarence Tel: +44 (0) 20 7597 5970
---------------------------- --------------------------
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in